Verrica製藥 VRCA 深 滬
已收盤 07-02 16:00:00 美东时间
6.135
+0.195
+3.28%
華盛通- 最 高6.18
- 今 開5.95
- 成交量 2.29万股
- 最 低 5.95
- 昨 收 5.94
- 總市值 1.05亿
- 52周最高 9.8212
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 3.28
- 委 比 35.40%
- 總股本 1717.88万
- 歷史最高 232.90
- 量 比 0.37
- 振 幅 3.87%
- 歷史最低 3.816
- 每 手 1
- 風險率 1.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 市值直指1.8万亿美元？瑞银给出美光1600美元天价目标！华尔街绩前集体上调迈威尔科技目标价
今日重点评级关注：Canaccord Genuity：维持Dakota Gold"投机性买入"评级，目标价从16美元升至18美元；瑞杰金融：上调Tectonic Therapeutic评级至"强烈买入"，目标价从76美元升至81美元
05-27 17:33
HC Wainwright & Co. Assumes Verrica Pharmaceuticals at Buy, Announces Price Target of $12
HC Wainwright & Co. analyst Raghuram Selvaraju assumes Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy rating and announces Price Target of $12.
05-26 18:51
Transcript: Verrica Pharmaceuticals Q1 2026 Earnings Conference Call
On Tuesday, Verrica Pharmaceuticals (NASDAQ:VRCA) discussed first-quarter finan...
05-13 17:16
Verrica Pharmaceuticals Q1 Adj. EPS $(0.41) Misses $(0.38) Estimate, Sales $5.023M Beat $4.520M Estimate
Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.38) by 7.89 percent. This is a 53.41 percent increase over losses of $(0.88) per
05-13 04:01
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Verrica Pharma To Present Phase 2 Clinical Data Highlighting Potential Abscopal Effects Of Oncolytic Peptide, VP-315, In Treatment Of Basal Cell Carcinoma At 2026 SID Annual Meeting
Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica")
05-06 04:46
Verrica Pharmaceuticals Q4 Adj. EPS $(0.51) Beats $(0.79) Estimate, Sales $5.092M Beat $4.525M Estimate
Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.79) by 35.77 percent. This is a 71.67 percent increase over losses of $(1.80) per
03-11 20:01
Earnings Scheduled For March 11, 2026
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
Verrica Pharmaceuticals Inc. will host a conference call and live webcast on March 11, 2026, at 8:30 a.m. ET to discuss its fourth-quarter and full-year 2025 financial results and provide a corporate update. Participants can join by dialing 1-800-343-4136 (US) or 1-203-518-9843 (international) with conference ID: VERRICA, or via webcast on the investor relations section of www.verrica.com. The webcast will be archived for 90 days. Verrica is a de...
03-05 13:00
